We came across a bullish thesis on Becton, Dickinson and Company on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on BDX. Becton, Dickinson and Company's share was trading at $176.66 as of February 26th. BDX’s trailing and forward P/E were 35.03 and 12.82, respectively according to Yahoo Finance.
[caption id="attachment_668561" align="aligncenter" width="750"]Becton, Dickinson and Company (BDX) remains a steady healthcare leader supported by durable, recurring demand across medical devices and diagnostics,...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.